Log in to search using one of your social media accounts:

 

Hormonal injection approved for treatment of hypoparathyroidism
The FDA recently approved a parathyroid hormone product, Natpara (NPS Pharmaceuticals), to control hypocalcaemia in patients with hypoparathyroidism. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 28, 2015 Category: Endocrinology Source Type: news

Postoperative symptomatic hypocalcaemia linked to preoperative vitamin D deficiency in thyroid cancer patients
In a study presented at the American Thyroid Association Annual Meeting researchers from Yonsei University College of Medicine evaluated postoperative thyroid cancer patients to determine if preoperative Vitamin D deficiency is associated with postoperative symptomatic hypocalcaemia. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 4, 2014 Category: Endocrinology Source Type: news

Society for Endocrinology Emergency Endocrine Guidance
The Society for Endocrinology’s Clinical Committee has produced Emergency Endocrine Guidance for three potentially life-threatening conditions which would necessitate urgent treatment: Acute Hypercalcaemia, Acute Hypocalcaemia (in adults) and Pituitary Apoplexy. These documents are targeted at health professionals and the emergency services and aim to provide emergency guidance through the initial phase of assessment and management of the patient. These documents are available to download from the Society website http://www.endocrinology.org/policy/ and will be published for distribution in the near future. We...
Source: Society for Endocrinology - July 15, 2013 Category: Endocrinology Source Type: news

How is acute hyperphosphataemia treated in adults?
Source: Leeds Medicines Information Centre Area: Evidence> Medicines Q & A There are no national guidelines for the treatment of acute hyperphosphataemia, and practice varies widely between hospital Trusts. The guidance in this Medicines Q&A reflects practice at Leeds Teaching Hospitals NHS Trust. The cause of the hyperphosphataemia should be established and treated. Most patients with hyperphosphataemia are asymptomatic. If symptoms are present, they are usually reflective of underlying contributory pathologies. Acute severe hyperphosphataemia with symptomatic hypocalcaemia can be life-threatening and ...
Source: NeLM - Medicines Q and A - February 26, 2013 Category: Drugs & Pharmacology Source Type: news